Details for New Drug Application (NDA): 076571
✉ Email this page to a colleague
The generic ingredient in CLADRIBINE is cladribine. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cladribine profile page.
Summary for 076571
Tradename: | CLADRIBINE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | cladribine |
Patents: | 0 |
Suppliers and Packaging for NDA: 076571
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLADRIBINE | cladribine | INJECTABLE;INJECTION | 076571 | ANDA | Fresenius Kabi USA, LLC | 63323-140 | 63323-140-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-140-10) / 10 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
Approval Date: | Apr 22, 2004 | TE: | AP | RLD: | No |
Complete Access Available with Subscription